Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study

The goal of treatment in patients with pulmonary arterial hypertension is to achieve a low risk status, indicating a favorable long-term outcome. The REPLACE study investigated the efficacy of switching to riociguat in patients with pulmonary arterial hypertension and an insufficient response to pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonneau, Gérald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Rosenkranz, Stephan, Grünig, Ekkehard, White, Jim, McLaughlin, Vallerie V., Langleben, David, Meier, Christian, Busse, Dennis, Kleinjung, Frank, Benza, Raymond L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734510/
https://www.ncbi.nlm.nih.gov/pubmed/33354316
http://dx.doi.org/10.1177/2045894020973124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734510/
https://www.ncbi.nlm.nih.gov/pubmed/33354316
http://dx.doi.org/10.1177/2045894020973124

Ejemplares similares